{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:41:11Z","timestamp":1789684871646,"version":"4.0.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Fatty acid metabolism (FAM) affects the immune phenotype in a metabolically dynamic tumor microenvironment (TME), but the use of FAM-related genes (FAMGs) to predict the prognosis and immunotherapy response of cutaneous melanoma (CM) patients has not been investigated. In this study, we aimed to construct FAM molecular subtypes and identify key prognostic biomarkers in CM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used a CM dataset in The Cancer Genome Atlas (TCGA) to construct FAM molecular subtypes. We performed Kaplan\u2013Meier (K-M) analysis, gene set enrichment analysis (GSEA), and TME analysis to assess differences in the prognosis and immune phenotype between subtypes. We used weighted gene co-expression network analysis (WGCNA) to identify key biomarkers that regulate tumor metabolism and immunity between the subtypes. We compared overall survival (OS), progression-free survival (PFS), and disease-specific survival (DSS) between CM patients with high or low biomarker expression. We applied univariable and multivariable Cox analyses to verify the independent prognostic value of the FAM biomarkers. We used GSEA and TME analysis to investigate the immune-related regulation mechanism of the FAM subtype biomarker. We evaluated the immune checkpoint inhibition (ICI) response and chemotherapy sensitivity between CM patients with high or low biomarker expression. We performed real-time fluorescent quantitative PCR (qRT-PCR) and semi-quantitative analysis of the immunohistochemical (IHC) data from the Human Protein Atlas to evaluate the mRNA and protein expression levels of the FAM biomarkers in CM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 2 FAM molecular subtypes (cluster 1 and cluster 2). K-M analysis showed that cluster 2 had better OS and PFS than cluster 1 did. GSEA showed that, compared with cluster 1, cluster 2 had significantly upregulated immune response pathways. The TME analysis indicated that immune cell subpopulations and immune functions were highly enriched in cluster 2 as compared with cluster 1. WGCNA identified 6 hub genes (<jats:italic>ACSL5, ALOX5AP, CD1D, CD74, IL4I1, and TBXAS1<\/jats:italic>) as FAM biomarkers. CM patients with high expression levels of the six biomarkers had better OS, PFS, and DSS than those with low expression levels of the biomarkers. The Cox regression analyses verified that the 6 FAM biomarkers can be independent prognostic factors for CM patients. The single-gene GSEA showed that the high expression levels of the 6 genes were mainly enriched in T-cell antigen presentation, the PD-1 signaling pathway, and tumor escape. The TME analysis confirmed that the FAM subtype biomarkers were not only related to immune infiltration but also highly correlated with immune checkpoints such as PD-1, PD-L1, and CTLA-4. TIDE scores confirmed that patients with high expression levels of the 6 biomarkers had worse immunotherapy responses. The 6 genes conveyed significant sensitivity to some chemotherapy drugs. qRT-PCR and IHC analyses verified the expression levels of the 6 biomarkers in CM cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our FAM subtypes verify that different FAM reprogramming affects the function and phenotype of infiltrating immune cells in the CM TME. The FAM molecular subtype biomarkers can be independent predictors of prognosis and immunotherapy response in CM patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.967277","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T10:43:40Z","timestamp":1668768220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Identification of fatty acid metabolism\u2013related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Yujian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pcmr.12661","article-title":"Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications","volume":"31","author":"Fischer","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0066","article-title":"Genomic approaches to understanding response and resistance to immunotherapy","volume":"22","author":"Braun","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/14737140.2020.1745634","article-title":"Melanoma immunotherapy: strategies to overcome pharmacological resistance","volume":"20","author":"Trojaniello","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa012","article-title":"Clinicopathological features, staging, and current approaches to treatment in high-risk resectable melanoma","volume":"112","author":"Keung","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15285","article-title":"Evaluation of the agreement between TNM 7th and 8th in a population-based series of cutaneous melanoma","volume":"33","author":"Crocetti","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3922","article-title":"Safety, efficacy, and biomarker analysis of toripalimab in previously treated advanced melanoma: Results of the POLARIS-01 multicenter phase II trial","volume":"26","author":"Tang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12967-017-1310-9","article-title":"World-wide immunoscore task force: meeting report from the \"Melanoma bridge\", napoli, November 30th-December 3rd, 2016","volume":"15","author":"Galon","year":"2017","journal-title":"J Transl Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2020.1729692","article-title":"Immunoscore: a novel prognostic tool. association with clinical outcome, response to treatment and survival in several malignancies","volume":"57","author":"Ros-Mart\u00ednez","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3410","article-title":"Study and analysis of antitumor resistance mechanism of PD1\/PD-L1 immune checkpoint blocker","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32835b651e","article-title":"Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy","volume":"25","author":"Hainaut","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci Adv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645242","article-title":"Fundamentals of T cell metabolism and strategies to enhance cancer immunotherapy","volume":"12","author":"Rangel Rivera","year":"2021","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.591342","article-title":"Metabolic reprogramming induces immune cell dysfunction in the tumor microenvironment of multiple myeloma","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2356","article-title":"LNMICC promotes nodal metastasis of cervical cancer by reprogramming fatty acid metabolism","volume":"78","author":"Shang","year":"2018","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2021.02.010","article-title":"Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy","volume":"20","author":"Ding","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002356","article-title":"Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","article-title":"SnapShot: TCGA-analyzed tumors","volume":"173","author":"Blum","year":"2018","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2015.0032","article-title":"A novel approach to high-quality postmortem tissue procurement: The GTEx project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreserv Biobank"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Consortium. 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: Database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14639","article-title":"Principal component analysis","volume":"58","author":"Hess","year":"2018","journal-title":"Transfusion"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12859-018-2435-4","article-title":"Single sample scoring of molecular phenotypes","volume":"19","author":"Foroutan","year":"2018","journal-title":"BMC Bioinf"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki005","article-title":"STRING: known and predicted protein-protein associations, integrated and transferred across organisms","volume":"33","author":"von Mering","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","article-title":"A general framework for weighted gene co-expression network analysis","volume":"4","author":"Zhang","year":"2005","journal-title":"Stat Appl Genet Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm369","article-title":"GSEA-p: a desktop application for gene set enrichment analysis","volume":"23","author":"Subramanian","year":"2007","journal-title":"Bioinf (Oxford England)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12859-021-04472-2","article-title":"Asc-seurat: analytical single-cell seurat-based web application","volume":"22","author":"Pereira","year":"2021","journal-title":"BMC Bioinf"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110194","article-title":"Dimensionality reduction and visualisation of hyperspectral ink data using t-SNE","volume":"311","author":"Melit Devassy","year":"2020","journal-title":"Forensic Sci Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giz087","article-title":"Ascend: R package for analysis of single-cell RNA-seq data","volume":"8","author":"Senabouth","year":"2019","journal-title":"Gigascience"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170804143706","article-title":"Immune checkpoint inhibitors: Basics and challenges","volume":"26","author":"Li","year":"2019","journal-title":"Curr Med Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp Mol Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13407","article-title":"TIGIT as an emerging immune checkpoint","volume":"200","author":"Harjunp\u00e4\u00e4","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3917040","article-title":"Bioinformatic profiling identifies a fatty acid metabolism-related gene risk signature for malignancy, prognosis, and immune phenotype of glioma","volume":"2019","author":"Qi","year":"2019","journal-title":"Dis Markers"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108822","article-title":"Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes","volume":"314","author":"Samson","year":"2019","journal-title":"Chem Biol Interact"},{"key":"B51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.12.011","article-title":"AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1","volume":"340","author":"Lee","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.380","article-title":"The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several b-cell lymphomas and by tumor-associated macrophages","volume":"23","author":"Carbonnelle-Puscian","year":"2009","journal-title":"Leukemia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041119","article-title":"IL4I1: an inhibitor of the CD8+ antitumor T-cell response","volume":"41","author":"Lasoudris","year":"2011","journal-title":"vivo. Eur J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445000","article-title":"The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation","volume":"45","author":"Cousin","year":"2015","journal-title":"Eur J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.03.019","article-title":"ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study","volume":"83","author":"Rajkumar","year":"2018","journal-title":"Metabolism"},{"key":"B59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10565-020-09520-w","article-title":"Roles of acyl-CoA synthetase long-chain family member 5 and colony stimulating factor 2 in inhibition of palmitic or stearic acids in lung cancer cell proliferation and metabolism","volume":"37","author":"Zhang","year":"2021","journal-title":"Cell Biol Toxicol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i40.14855","article-title":"Modulating effects of acyl-CoA synthetase 5-derived mitochondrial Wnt2B palmitoylation on intestinal wnt activity","volume":"20","author":"Klaus","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.005","article-title":"Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing","volume":"133","author":"Gassler","year":"2007","journal-title":"Gastroenterology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0155660","DOI":"10.1371\/journal.pone.0155660","article-title":"Systematic analysis of gene expression alterations and clinical outcomes for long-chain acyl-coenzyme a synthetase family in cancer","volume":"11","author":"Chen","year":"2016","journal-title":"PLos One"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020236","article-title":"Cross-talk between cancer cells and the tumour microenvironment: The role of the 5-lipoxygenase pathway","volume":"18","author":"Moore","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.675104","article-title":"ALOX5AP predicts poor prognosis by enhancing M2 macrophages polarization and immunosuppression in serous ovarian cancer microenvironment","volume":"11","author":"Ye","year":"2021","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1321-6","article-title":"Implication of the \u03b22-microglobulin gene in the generation of tumor escape phenotypes","volume":"61","author":"Bernal","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2018.04.021","article-title":"Immune evasion of the CD1d\/NKT cell axis","volume":"52","author":"Brutkiewicz","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01132","article-title":"Blockade of MIF-CD74 signalling on macrophages and dendritic cells restores the antitumour immune response against metastatic melanoma","volume":"9","author":"Figueiredo","year":"2018","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27646","article-title":"Macrophage polarity in cancer: A review","volume":"120","author":"Najafi","year":"2019","journal-title":"J Cell Biochem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12752","article-title":"Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model","volume":"106","author":"Minami","year":"2015","journal-title":"Cancer Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9371","article-title":"Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations: evidence for selective pressure","volume":"26","author":"Ulrich","year":"2005","journal-title":"Hum Mutat"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0716","article-title":"Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival","volume":"15","author":"Abraham","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.967277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T10:43:48Z","timestamp":1668768228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.967277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2022.967277"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.967277","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"article-number":"967277"}}